Masco (MAS) vs Smith & Nephew SNATS (SNN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Masco (MAS) has outperformed Smith & Nephew SNATS (SNN) over the past year, gaining 1.0% versus a loss of 25.0%. Over five years, MAS leads with a +16.2% price change compared with -23.8% for SNN. Masco is the larger company by market cap ($13.70 billion vs $11.28 billion), about 1.2 times the size, while Smith & Nephew SNATS is growing revenue faster (+6.1% vs -3.4%).
On valuation, Smith & Nephew SNATS trades at a lower forward P/E (11.2x vs 15.0x for Masco). Masco offers the higher dividend yield (1.81% vs 1.47%). Masco converts more of its revenue into profit, with a net margin of 10.7% versus 10.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MAS | SNN |
|---|---|---|
| Share price | $69.50 | $26.96 |
| Market cap | $13.70B | $11.28B |
| 1-day change | +0.91% | +0.26% |
| YTD return | +9.52% | -17.83% |
| 1-year return | +1.00% | -24.97% |
| 5-year return | +16.20% | -23.82% |
| P/E ratio (TTM) | 16.01 | 18.34 |
| Forward P/E | 14.99 | 11.18 |
| EPS (TTM) | $4.34 | $1.47 |
| Dividend yield | 1.81% | 1.47% |
| Annual dividend | $1.26 | $0.397 |
| Revenue (latest FY) | $7.56B | $6.16B |
| Revenue growth (YoY) | -3.40% | +6.09% |
| Net income (latest FY) | $810.00M | $625.00M |
| Gross margin | 35.43% | 68.01% |
| Operating margin | 16.50% | 12.88% |
| Net margin | 10.71% | 10.14% |
| 52-week high | $83.64 | $37.51 |
| 52-week low | $58.16 | $26.12 |
| Distance from 52-week high | -16.91% | -28.13% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +15.18% | +19.88% |
| Average volume | 2.36M | 1.65M |
| Shares outstanding | 197.19M | 418.52M |
| Employees | 18,000 | 17,000 |
| Sector | Industrials | Healthcare |
| Industry | Industrial Specialties | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MAS has outperformed SNN by 26.0 percentage points over the past year.
- Smith & Nephew SNATS grew revenue faster in its latest fiscal year (+6.09% vs -3.40%).
- The two companies sit in different sectors: Masco in Industrials and Smith & Nephew SNATS in Healthcare.
About Masco
MAS stock →Masco Corporation provides home improvement and building products in North America, Europe, and internationally. The company's Plumbing Products segment offers faucets, showerheads, handheld showers, valves, bath hardware and accessories, bathing units, shower bases and enclosures, shower drains, steam shower systems, water filtration systems, and sinks and kitchen accessories; acrylic tubs, bath and shower enclosures, and shower bases and trays; spas, exercise pools, and aquatic fitness systems and saunas; brass, copper, and composite plumbing system component and other non-decorative plumbing products; water products; and thermoplastic products, extruded plastic profiles, and specialized fabrication products, as well as PEX tubing products.
Industrials · Industrial Specialties · 18,000 employees
About Smith & Nephew SNATS
SNN stock →Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Healthcare · Medical Devices · 17,000 employees
MAS vs SNN FAQ
Which is bigger, Masco or Smith & Nephew SNATS?
Masco (MAS) is larger, with a market capitalization of $13.70B compared with $11.28B for Smith & Nephew SNATS (SNN).
Which stock has performed better over the past year, MAS or SNN?
MAS returned +1.00% over the past 12 months, compared with -24.97% for SNN (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, MAS or SNN?
MAS has the lower trailing P/E at 16.0, versus 18.3 for SNN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Masco or Smith & Nephew SNATS?
Masco has the higher yield at 1.81%, compared with 1.47% for Smith & Nephew SNATS.
Are Masco and Smith & Nephew SNATS in the same industry?
No. Masco is in the Industrials sector, while Smith & Nephew SNATS is in Healthcare.